Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation

M. M. Barroso; A. Vázquez-Armendariz; L. Jankauskaite; I. Alexopoulos; S. Günther; S. Reischauer; T. Braun; S. Herold

doi:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation

M. M. Barroso^*
, A. Vázquez-Armendariz
, L. Jankauskaite
, I. Alexopoulos
, S. Günther
, S. Reischauer
, T. Braun
, S. Herold

^*Corresponding author for this work

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	A4361-A4361
Number of pages	1
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	209
DOIs	https://doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361
Publication status	Published - May 2024
Externally published	Yes
Event	American Thoracic Society 2024 International Conference - San Diego, United States Duration: 17 May 2024 → 22 May 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

Cite this

Barroso, M. M., Vázquez-Armendariz, A., Jankauskaite, L., Alexopoulos, I., Günther, S., Reischauer, S., Braun, T., & Herold, S. (2024). Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation. American Journal of Respiratory and Critical Care Medicine, 209, A4361-A4361. https://doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

Barroso, M. M. ; Vázquez-Armendariz, A. ; Jankauskaite, L. et al. / Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation. In: American Journal of Respiratory and Critical Care Medicine. 2024 ; Vol. 209. pp. A4361-A4361.

@article{9145494e3ab44847ade31ff6233ee975,

title = "Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation",

author = "Barroso, \{M. M.\} and A. V{\'a}zquez-Armendariz and L. Jankauskaite and I. Alexopoulos and S. G{\"u}nther and S. Reischauer and T. Braun and S. Herold",

year = "2024",

month = may,

doi = "10.1164/ajrccm-conference.2024.209.1\_meetingabstracts.a4361",

language = "English",

volume = "209",

pages = "A4361--A4361",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

note = "American Thoracic Society 2024 International Conference ; Conference date: 17-05-2024 Through 22-05-2024",

}

Barroso, MM, Vázquez-Armendariz, A, Jankauskaite, L, Alexopoulos, I, Günther, S, Reischauer, S, Braun, T & Herold, S 2024, 'Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation', American Journal of Respiratory and Critical Care Medicine, vol. 209, pp. A4361-A4361. https://doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation. / Barroso, M. M.; Vázquez-Armendariz, A.; Jankauskaite, L. et al.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 209, 05.2024, p. A4361-A4361.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation

AU - Barroso, M. M.

AU - Vázquez-Armendariz, A.

AU - Jankauskaite, L.

AU - Alexopoulos, I.

AU - Günther, S.

AU - Reischauer, S.

AU - Braun, T.

AU - Herold, S.

PY - 2024/5

Y1 - 2024/5

U2 - 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

DO - 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361

M3 - Meeting Abstract

SN - 1073-449X

VL - 209

SP - A4361-A4361

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

T2 - American Thoracic Society 2024 International Conference

Y2 - 17 May 2024 through 22 May 2024

ER -

Barroso MM, Vázquez-Armendariz A, Jankauskaite L, Alexopoulos I, Günther S, Reischauer S et al. Influenza-infected alveolar epithelial cell have increased resilience after bone-marrow-derived mesenchymal stem cell therapeutic delivery, via type I interferon and interleukin 11 signalling axis activation. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:A4361-A4361. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4361